Modular Medical (Nasdaq:MODD) announced recently that it priced an underwritten public offering worth proceeds of around $8.2 ...

Abbott modified its original FreeStyle Libre 2 for the purpose of integration with automated insulin delivery systems. It ...

Medtronic announced today that it received FDA clearance for its new InPen insulin delivery system application.

Abbott announced today that it officially opened a new state-of-the-art manufacturing facility in Kilkenny, Ireland.

Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.

Medtronic (NYSE:MDT) has plans to submit its MiniMed 780G for an expanded indication from the FDA for type 2 diabetes in the near future.

The FreeStyle Libre 3 Plus worn during an imaging procedure. [Image courtesy of Abbott] Abbott (NYSE:ABT) announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during ...

[Image courtesy of Dexcom/Oura] Dexcom (Nasdaq:DXCM) announced today that it entered into a strategic partnership with Oura, maker of leading smart ring technology. The partnership aims to help people ...